• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Assessment of expression level of intestinal antibacterial peptides in ulcerative colitis as a biomarker for pouchitis

Research Project

Project/Area Number 18K08611
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionTohoku University

Principal Investigator

Watanabe Kazuhiro  東北大学, 大学病院, 助教 (30569588)

Project Period (FY) 2018-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2020: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords潰瘍性大腸炎 / 家族性大腸腺腫症 / 回腸嚢炎 / 抗菌ペプチド / 腸内細菌 / 短鎖脂肪酸 / 有機酸 / 大腸全摘 / 抗菌タンパク / RELMβ
Outline of Final Research Achievements

Mucosal samples of ileal pouch in patients with ulcerative colitis (UC) and familial adenomatous polyposis (FAP) who underwent total colectomy and ileal pouch anal anastomosis were collected. The quantification of mRNA for intestinal-derived antibacterial proteins/peptides (Resistin- like moleculeβ(RELM-β)、Human β defensin 1 (hBD1)、and Human α defensin 5 (HD5)) was performed by the RT-PCR method. There was no significant difference in the expression levels between UC and FAP, but the expression levels of RELM-β and hBD1 were significantly reduced in cases of 2 years or more compared to within 1 year after stoma closure (p=0.04, p=0.02). Similarly, the expression levels of RELM-β and hBD1 were significantly reduced in cases 2 years or more compared to cases 1-2 years after stoma closure (p=0.04, p=0.02). There was no clear difference between the presence and absence of pouchitis.

Academic Significance and Societal Importance of the Research Achievements

潰瘍性大腸炎の大腸全摘・回腸嚢肛門吻合術後の合併症として回腸嚢炎があり、術後管理の大きな問題となっている。回腸嚢炎の原因は不明であるが、抗菌剤が著効することから腸内細菌叢との関連が示唆されている。今回、腸管から分泌される内因性抗菌タンパク/ペプチド(AMPs)に着目し検討を行い、経時的にAMPsの発現量が変化することを示した。腸内細菌は、経時的に健常人の細菌叢に近づく傾向を認める一方で、潰瘍性大腸炎ではPrevotella属の増加などの特徴を認めており、これらが回腸嚢炎の発症に関与している可能性が示唆された。

Report

(4 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi